Foreign IP strategy for manufacturing executives

By Michael Bielski

Michael Bielski

Michael Bielski New York | North America
Asst. Di at Center for Bi
Consulting/Research
Analysis/Consulting


Globalization has created significant opportunities for manufacturing companies in the outsource contract manufacturing sector — across various end-market segments and industries. However, along with these opportunities has surfaced an unwanted risk against one of a company’s most valuable assets – its intellectual property (IP), including patents and trade secrets.

The increase in a company’s IP risk profile warrants placing ever more importance on foreign patent filing IP strategies developed and implemented by companies and, the growing role that business, product marketing, and technical executives must play in developing company IP strategy in conjunction with sound legal counsel.

Foreign patent filing IP strategies have significant implications regarding the scope of patent rights afforded to a company. Business, marketing, and technical executives don’t necessarily have to understand the minutia of patent prosecution, however, these executives should be intimately involved in strategic decisions regarding which jurisdictions companies should pursue product patent protection.

This decision process should not be ad-hoc. IP strategy and foreign patent filing decisions must be aligned with a company’s business priorities, objectives, and goals.

Foreign patent filing diversity

As an example of how diverse and comprehensive foreign patent filing IP strategies can be, let’s look at jurisdictional patent family members for patents filed — whose primary US Class is 600/300 – for medical surgery, diagnostic testing products.

Table 1 displays foreign and domestic applications from 1997 to 2007. Note: PCT refers to Patent Cooperation Treaty.

Table 1
United States Class 600/300
Filing Jurisdictions
Medical Surgery &
Diagnostic Testing Products
Country Original Patents
Slovakia 1
Singapore 2
Turkey 2
Argentina 3
Greece 4
Latvia 4
Indonesia 5
Netherlands 5
Italy 6
Czech Republic 8
Finland 9
Switzerland 15
Hong Kong 16
Poland 18
South Africa 19
Portugal 20
Hungary 21
Urasian 24
France 25
Ukraine 26
Denmark 36
Sweden 42
Taiwan 45
Russia 59
Norway 75
United Kingdom 84
Spain 104
South Korea 114
Mexico 148
New Zealand 149
Israel 188
Brazil 192
Austria 273
China 343
Germany 684
Japan 1,029
Canada 1,109
Australia 1,971
European 2,505
PCT 3,025
United States 10,457
Total 22,865

As illustrated above, companies in this particular medical technology space filed foreign patent filings in more than 35 jurisdictions — at tremendous cost. Although the United States is the dominant jurisdiction, many other jurisdictions have also been integral to the foreign patent filing IP strategies for the organizations filing.

Foreign patent filing IP strategy considerations

How do executives choose which jurisdictions to file patents in? How can executives align their foreign patent filing IP strategy with their company’s strategic business objectives in a cost-effective manner?


Ask a Question in Q&A  or click here to leave a comment

My question pertains to the article on this page.


Tags (optional)

Human Verification (required) 5 - 4 =

  or log in or sign up    

You can ask questions anonymously whether or not you are a member of VO GlobalNet. However, by logging in and asking questions in your name you will receive an email notice whenever a user answers your question. Plus, you can build your reputation with site users.


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

You might also like:

VIDEO - Apple manufacturing, supply chain problems extend beyond suppliers